Xontogeny

About The Fund

Xontogeny is a life sciences accelerator based in Boston, Massachusetts, founded in 2016 with a focus on empowering entrepreneurs and companies within the pharmaceutical and biotechnology sectors. They collaborate closely with scientific founders, entrepreneurs, and first-time CEOs to lead the successful development of innovative technologies that hold the potential to offer new treatment options for patients with serious diseases. Xontogeny provides a robust platform for the growth of life sciences ventures, which includes an experienced team, a broad network of industry consultants, and a range of service providers. Their support system encompasses seed investment capital over various technologies comprising therapeutics, diagnostics, and devices. They prioritize guiding each program to achieve a meaningful clinical proof-of-concept study. Through cultivation of partnerships and fostering collaboration, Xontogeny works alongside knowledgeable individuals to devise creative solutions and reach key milestones, thereby accelerating the advancement of new technologies. Their approach entails offering more than just funding; they engage deeply in the strategic and operational aspects of their portfolio companies, designed to navigate through the early stages of development. They maintain connection within their community, bridging relationships between researchers, pharmaceutical industries, investors, and industry organizations. Their diverse portfolio showcases their commitment to seed investments, incubating a pipeline of early-stage life sciences companies that span a wide spectrum of modalities and therapeutic areas. Staying active in the life sciences ecosystem involves offering insights through the latest news and giving the community opportunities to engage with Xontogeny through various channels, with the goal of shaping the future of the industry.